Ength, kb Model 1 Model two Arachidic acid (20:0), of energy Telomere length, kb Model 1 Model two Behenic acid (22:0), of energy Telomere length, kb Model 1 Model two Quartile 1 0.29 4.11 (four.03, 4.20) 4.13 (4.03, 4.24) 0.08 4.12 (4.04, 4.21) four.12 (4.02, four.23) 0.03 four.12 (four.03, four.20) 4.12 (4.02, four.23) 0.03 4.13 (four.04, four.21) 4.15 (four.04, four.26) 0.06 four.11 (four.02, four.19) four.13 (four.02, four.24) 0.08 4.11 (four.03, 4.20) 4.14 (four.03, 4.25) six.03 four.08 (3.99, 4.16) 4.12 (four.01, 4.23) 0.39 4.11 (four.03, four.20) four.13 (four.02, 4.24) 3.74 4.08 (four.00, four.17) 4.13 (four.01, 4.24) 0.01 four.04 (3.96, 4.13) 4.04 (3.93, four.14) 1.71 four.07 (3.98, 4.15) 4.11 (three.99, 4.22) 0.02 four.03 (three.95, four.12) four.05 (3.94, 4.16) 0.01 3.98 (three.90, four.07) 3.98 (3.87, 4.09) Quartile 2 0.55 four.09 (four.01, 4.18) 4.11 (four.00, 4.21) 0.15 4.09 (4.00, four.17) four.12 (4.01, 4.22) 0.07 4.13 (four.04, four.21) 4.14 (four.04, four.25) 0.06 four.12 (four.04, 4.21) 4.13 (4.02, four.23) 0.11 4.13 (four.04, four.21) four.13 (four.03, four.24) 0.15 4.05 (3.97, 4.14) 4.07 (3.96, four.18) 8.18 four.13 (four.05, four.22) 4.17 (4.06, 4.28) 0.65 4.10 (four.01, four.18) four.13 (four.02, 4.23) four.99 4.11 (4.03, 4.20) four.16 (4.05, four.27) 0.02 4.18 (4.09, 4.26) 4.20 (4.10, four.31) two.40 four.13 (four.05, 4.22) four.18 (four.07, 4.29) 0.03 4.06 (3.97, four.14) 4.08 (three.97, four.19) 0.02 4.10 (four.02, four.19) 4.14 (four.03, four.24) Quartile three 0.83 4.06 (3.98, 4.15) 4.10 (3.99, 4.21) 0.22 4.09 (4.00, 4.17) four.12 (4.77545-45-0 Purity 01, 4.23) 0.11 4.06 (three.98, four.15) 4.11 (4.00, four.23) 0.09 four.05 (3.97, 4.14) 4.09 (3.98, four.20) 0.17 4.08 (three.99, four.16) four.12 (4.01, four.23) 0.23 four.05 (three.97, four.14) 4.09 (three.99, 4.20) ten.2-Chloro-6-methyl-5-nitronicotinonitrile site ten four.PMID:33650139 02 (3.94, four.11) 4.05 (3.95, four.16) 0.86 4.07 (three.98, 4.15) four.10 (3.99, 4.21) six.08 4.05 (3.97, four.14) 4.08 (3.97, four.19) 0.03 4.02 (three.94, 4.11) four.06 (3.96, 4.17) 3.03 4.02 (three.94, four.11) 4.05 (3.95, 4.16) 0.04 4.04 (3.96, 4.13) four.08 (3.97, 4.18) 0.03 four.06 (three.98, four.15) four.11 (four.00, 4.22) Quartile four 1.29 3.95 (3.86, 4.04) four.00 (3.89, 4.11) 0.36 3.92 (3.84, 4.01) 3.98 (3.87, 4.09) 0.18 3.91 (3.83, 4.00) three.96 (three.85, four.07) 0.13 three.92 (three.83, four.00) three.97 (3.86, four.08) 0.26 three.91 (3.82, 3.99) 3.95 (3.84, 4.07) 0.38 4.00 (three.92, four.09) 4.04 (3.93, four.15) 12.60 3.98 (3.90, 4.07) four.00 (three.89, 4.12) 1.23 3.94 (three.85, four.02) 3.98 (3.87, four.09) 7.51 3.97 (3.88, four.05) three.98 (3.87, 4.ten) 0.06 3.98 (3.89, four.06) 4.04 (three.93, four.15) three.84 3.99 (three.91, four.08) four.02 (three.90, 4.13) 0.07 4.09 (4.00, 4.17) 4.13 (four.02, 4.24) 0.08 four.08 (3.99, 4.16) four.13 (four.02, four.24) 0.005 0.046 Ptrend,0.001 0.,0.001 0.,0.001 0.,0.001 0.0.10 0.0.044 0.0.003 0.0.036 0.0.049 0.0.10 0.0.41 0.0.37 0.1 Values for telomere length are leastsquare implies (95 CIs). Values for every SFA are median intakes with the SFA according to quartiles. Model 1: adjusted for age (y, continuous); model 2: adjusted for age (y, continuous), raceethnicity (white, black, Hispanic, Asian/Pacific Islander), BMI (#25, .2530, .305, .35 kg/m2), smoking (in no way, former, present smoker), every day alcohol intake (#0.01, .0.01.1, .0.1, .two g/d), diabetes case within the primary casecontrol study (yes, no), physical activity (0, .0, .50, .20 metabolic equivalent hours/wk), and everyday intakes of energy (kcal, continuous), fruit and vegetables (medium serving [;170 g], continuous), vitamin C (mg, continuous), vitamin E (IU, continuous), selenium (mg, continuous), and bcarotene (mg, continuous). LSFA, longchain SFA; SMSFA, shorttomediumchain SFA; WHI, Girls Overall health Initiative. two P values for linear trend have been obtained by such as the median intake levels of every single group as continuous variables inside the regression models.Song et al.FIGURE 1 Estimated alterations in leukocyte te.